Filter
601 - 610 of 693 results
Results for

Support to AHRQ’s Primary Care Quality Improvement Initiative
Project
Primary care providers face multiple challenges, including underinvestment, workforce shortages, administrative burdens, and high patient volumes. They all are barriers to providing high quality and evidence-informed care.


Health Systems Research (HSR) 2024
Event
Abt Global is exhibiting and presenting at Health Systems Research (HSR) in Nagasaki, Japan in November 2024.

New Research Informs Nursing Home Staffing Minimums in the United States
Impact Brief
CMS contracted Abt to conduct the 2022 Nursing Home Staffing Study, and our findings informed the agency’s 2024 staffing policy.

Abt to Manage Australia’s Main Development Program for Fiji
News
The Australian Government recently awarded Abt Global a contract to manage a $90 million umbrella program covering half of Australia’s development assistance to Fiji.

Nurturing and Optimizing Networks of Care to Maximize Benefits to Patients, Health Workers, and Health Systems
Blog
In Global Health Science and Practice, Abt Global’s Kelly Saldana and coauthors argue for more evidence and coordination to expand the use of Networks of Care in health systems and service strengthening.

Preparing for Medicaid’s Transition to ACOs: Three Tips for States
Blog
In this blog, we offer tips to help states meets CMS’s goal of transitioning Medicaid managed care beneficiaries to accountable care relationships.

Lessons Learned from Private Sector Engagement Across Sectors
Blog
Sarah Kozyn’s and Sean Callahan’s Marketlinks blog details how engaging the private sector has helped health systems, renewable energy, and more across sectors.

Getting to 95+: Culture of Learning, Data-Use Drives Demand for HIV Services in Mozambique
Blog
By taking a fully integrated approach to data use and adaptation, the USAID ECHO project is closing in on 95-95-95 targets in only two years, amid cyclone, floods, and COVID.

Evaluating the Cell and Gene Therapy Access Model
Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.